Yuval Horn to co-chair a panel at the IBA World Life Sciences Conference in Dallas, Texas.
May 1, 2013
Horn & Co. Represents the Israeli Public Companies Organization in its dialogue with the ISA.
May 1, 2013
Yuval Horn noted as one of the 5 worldwide leading practitioners in Life Sciences Transactions.
April 1, 2013
Chambers Global ranks Yuval Horn as a leading Israeli practitioner in M&A: High Tech
March 1, 2013
Yuval Horn nominated as Chairperson of the IBA LifeSciences SubCommittee.
December 1, 2012
Immune Pharmaceuticals Ltd., and EpiCept Corporation entere into a definitive merger agreement.
November 8, 2012
Yuval Horn chairs a panel at the IBA Annual Conference in Dublin, Ireland (October 2012).
October 6, 2012
ANTI CORRUPTION REGULATION 2012
August 6, 2012
THE INTERNATIONAL WHO’S WHO OF LIFE SCIENCES LAWYERS 2013
August 6, 2012
Pfizer, Inc. and Protalix BioTherapeutics, Inc. announce that the FDA approved ELELYSO™.
May 6, 2012
